Vaccines & Biologics

CORBEVAX GETS DCGI APPROVAL

CORBEVAX is India’s 1st indigenously developed protein sub-unit COVID-19 Vaccine

  • CORBEVAX is a “recombinant protein sub-unit” vaccine, developed from a component of the spike protein on the virus’s surface, which helps the body build the immune response against the virus
  • The vaccine has the Receptor Binding Domain (RBD) protein as an antigen, and also an optimum adjuvant consisting of Dynavax (DVAX) CpG 1018 and alum
  • CORBEVAX is accorded Emergency Use Authorization as a COVID-19 vaccine and is available for consumption only in India via authorized channels

Click on the following for


×

The information on this website is intended for use only by residents of the United States of America. The product information on this site is provided for general information purposes only and is not intended to be a substitute for the actual approved product information. This information is neither medical advice nor a substitute for discussions with a qualified medical professional. The products listed are available only through prescription by a qualified medical professional. BE Pharmaceuticals Inc. and its affiliates shall not be responsible for the reliance on or use of any information contained herein. The reader understands and agrees to the foregoing.

I AgreeI Decline